Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
blackstone group
clinical trials
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
perimenopausal depression
praxis precision medicines
san francisco blog main
san francisco top stories
startups
steven petrou
aligos therapeutics
antisense oligonucleotide
azacitidine
baker brothers life sciences
benzodiazepine
benzodiazepines
beta-thalassemia
biogen
biotech ipos
blackstone life sciences
blepharitis
cavion
cephalgia
chronic hepatitis b virus
columbia university
dacogen
deals
What
drugs
3
×
medicines
3
×
research
3
×
aims
new
praxis
precision
approach
backed
based
biotech
biotechs
called
cause
central
ceo
cns
debuts
developing
disorder
emerged
epigenetic
epigenetics
epilepsy
field
flagship’s
genes
genetic
ipos
kept
leads
links
marcio
morning
mutations
nervous
neuro
omega
prep
quiet
Language
unset
Current search:
drugs
×
medicines
×
research
×
" new york top stories "
×
" boston top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further